Your session is about to expire
← Back to Search
Other
1 for Sickle Cell Anemia
Phase 1
Waitlist Available
Research Sponsored by GAAD Medical Research Institute Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
People with sickle cell disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 40 minutes
Awards & highlights
Study Summary
Most patients with sickle-cell disease have periodic intensely painful episodes. To manage this pain, we are proposing the drinking of at least 500 mL of water followed by far infrared radiation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 40 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~40 minutes
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Pain Management
Trial Design
1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
Far Infrared Radiation
Find a Location
Who is running the clinical trial?
GAAD Medical Research Institute Inc.Lead Sponsor
21 Previous Clinical Trials
85 Total Patients Enrolled
Ken Nedd, M.D.Study ChairGAAD Medical Research Institute Inc.
19 Previous Clinical Trials
83 Total Patients Enrolled
Kwasi Donyina, Ph.D.Study DirectorGAAD Medical Research Institute Inc.
13 Previous Clinical Trials
44 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger